A detailed history of Gyl Financial Synergies, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Gyl Financial Synergies, LLC holds 286,180 shares of PFE stock, worth $7.49 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
286,180
Previous 329,269 13.09%
Holding current value
$7.49 Million
Previous $9.21 Million 10.1%
% of portfolio
0.63%
Previous 0.72%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$27.7 - $31.39 $1.19 Million - $1.35 Million
-43,089 Reduced 13.09%
286,180 $8.28 Million
Q2 2024

Jul 23, 2024

SELL
$25.26 - $29.6 $213,042 - $249,646
-8,434 Reduced 2.5%
329,269 $9.21 Million
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $1.02 Million - $1.17 Million
-39,306 Reduced 10.43%
337,703 $9.37 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $607,548 - $789,138
23,251 Added 6.57%
377,009 $10.9 Million
Q3 2023

Nov 06, 2023

BUY
$32.09 - $37.51 $265,159 - $309,945
8,263 Added 2.39%
353,758 $11.7 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $2.88 Million - $3.33 Million
79,726 Added 30.0%
345,495 $12.7 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $9.54 Million - $12.4 Million
242,308 Added 1032.81%
265,769 $10.8 Million
Q4 2022

Feb 06, 2023

BUY
$41.75 - $54.5 $68,219 - $89,053
1,634 Added 7.49%
23,461 $1.2 Million
Q3 2022

Nov 01, 2022

BUY
$43.76 - $53.42 $612 - $747
14 Added 0.06%
21,827 $955,000
Q2 2022

Aug 01, 2022

BUY
$46.53 - $55.17 $177,372 - $210,308
3,812 Added 21.18%
21,813 $1.14 Million
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $165,523 - $205,104
-3,618 Reduced 16.74%
18,001 $932,000
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $53,798 - $79,747
1,302 Added 6.41%
21,619 $1.28 Million
Q3 2021

Nov 01, 2021

BUY
$39.25 - $50.42 $107,662 - $138,302
2,743 Added 15.61%
20,317 $874,000
Q2 2021

Aug 02, 2021

SELL
$35.91 - $40.68 $4,093 - $4,637
-114 Reduced 0.64%
17,574 $688,000
Q1 2021

May 04, 2021

SELL
$33.49 - $37.77 $423,246 - $477,337
-12,638 Reduced 41.67%
17,688 $641,000
Q4 2020

Feb 02, 2021

SELL
$33.47 - $42.56 $9,505 - $12,087
-284 Reduced 0.93%
30,326 $1.12 Million
Q3 2020

Nov 06, 2020

BUY
$31.75 - $37.25 $39,020 - $45,780
1,229 Added 4.18%
30,610 $1.12 Million
Q2 2020

Aug 04, 2020

SELL
$30.12 - $36.54 $40,270 - $48,853
-1,337 Reduced 4.35%
29,381 $961,000
Q1 2020

May 05, 2020

BUY
$27.03 - $38.62 $7,649 - $10,929
283 Added 0.93%
30,718 $1 Million
Q4 2019

Feb 06, 2020

BUY
$32.92 - $37.36 $26,039 - $29,551
791 Added 2.67%
30,435 $1.19 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $200,755 - $260,321
6,179 Added 26.33%
29,644 $1.07 Million
Q2 2019

Aug 09, 2019

BUY
$36.98 - $41.52 $17,676 - $19,846
478 Added 2.08%
23,465 $1.02 Million
Q1 2019

May 21, 2019

SELL
$37.5 - $41.2 $4.11 Million - $4.51 Million
-109,493 Reduced 82.65%
22,987 $976,000
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $4.55 Million - $5 Million
121,281 Added 1082.96%
132,480 $5.63 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $430,825 - $491,188
11,199 New
11,199 $489,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Gyl Financial Synergies, LLC Portfolio

Follow Gyl Financial Synergies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyl Financial Synergies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gyl Financial Synergies, LLC with notifications on news.